MTOR and breast cancer: Those SNPs were included in our pathway-based analysis because they are located in genes which are involved in the mTOR, PI3K, P53, and checkpoint pathways (Table 2), pathways have been found to be aberrant in breast cancer (The Cancer Genome Atlas Network, 2012).